TLCR Talecris Biotherapeutics Holdings Corp. (MM)

28.80

0.00 (0.00%)

14 Jun 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Talecris Biotherapeutics Holdings Corp. (MM)	NASDAQ:TLCR	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	28.80						0	01:00:00

Talecris Biotherapeutics to Report First Quarter 2011 Financial Results

14/04/2011 2:27pm

PR Newswire (US)

Talecris Biotherapeutics Holdings Corp. (MM) (NASDAQ:TLCR)
Historical Stock Chart

From Jun 2019 to Jun 2024

Click Here for more Talecris Biotherapeutics Holdings Corp. (MM) Charts.

RESEARCH TRIANGLE PARK, N.C., April 14, 2011 /PRNewswire/ -- Talecris Biotherapeutics Holdings Corp. (NASDAQ: TLCR) will issue its first quarter earnings release after the market closes on April 27, 2011. Due to the pending merger with Grifols, S.A., Talecris will not be hosting a conference call to discuss its first quarter results.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.

SOURCE Talecris Biotherapeutics, Inc.